{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:32:25Z","timestamp":1793298745732,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Projects Unit of Bezmialem Vakif University","award":["20230404E"],"award-info":[{"award-number":["20230404E"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01842-9","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:52:49Z","timestamp":1762959169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Mass spectrometry-based untargeted metabolomics study of polycystic ovary syndrome"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9034-4805","authenticated-orcid":false,"given":"\u00d6mer Faruk","family":"\u00d6zer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3235-4658","authenticated-orcid":false,"given":"Ay\u015fe Zeynep","family":"\u0130brahimo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-1054","authenticated-orcid":false,"given":"Ay\u015fe Zehra","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4810-6771","authenticated-orcid":false,"given":"Metin","family":"Demirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9244-6752","authenticated-orcid":false,"given":"Seda","family":"Ate\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9998-4948","authenticated-orcid":false,"given":"Havva Sevde","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9058-9670","authenticated-orcid":false,"given":"Merve","family":"\u0130brahimo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1235-3957","authenticated-orcid":false,"given":"\u015eahabettin","family":"Selek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"1842_CR1","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, Dunaif A, Laven JSE, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.","journal-title":"Nat Rev Dis Primers"},{"key":"1842_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14:270\u201384.","journal-title":"Nat Rev Endocrinol"},{"key":"1842_CR3","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ejogrb.2016.08.026","volume":"207","author":"F Orio","year":"2016","unstructured":"Orio F, Muscogiuri G, Nese C, Palomba S, Savastano S, Tafuri D, et al. Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an up-to-date in the management of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2016;207:214\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1842_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.metabol.2017.03.002","volume":"71","author":"AY Chang","year":"2017","unstructured":"Chang AY, Lalia AZ, Jenkins GD, Dutta T, Carter RE, Singh RJ, et al. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome. Metabolism. 2017;71:52\u201363.","journal-title":"Metabolism"},{"key":"1842_CR5","volume-title":"Amenorrhea","author":"I Draveck\u00e1","year":"2011","unstructured":"Draveck\u00e1 I, Lazurova I. Polycystic ovary syndrome. In: Chatterjee A, editor. Amenorrhea. Rijeka: IntechOpen; 2011."},{"key":"1842_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-3-319-45534-1_2","volume-title":"Infertility in women with polycystic ovary syndrome: pathogenesis and management","author":"F Orio","year":"2018","unstructured":"Orio F, Muscogiuri G. Diagnostic criteria for PCOS. In: Palomba S, editor. Infertility in women with polycystic ovary syndrome: pathogenesis and management. Cham: Springer International Publishing; 2018. pp. 11\u201321."},{"key":"1842_CR7","doi-asserted-by":"publisher","first-page":"100159","DOI":"10.1016\/j.endmts.2024.100159","volume":"14","author":"V Unfer","year":"2024","unstructured":"Unfer V, Kandaraki E, Pkhaladze L, Roseff S, Vazquez-Levin MH, Lagan\u00e0 AS, et al. When one size does not fit all: reconsidering PCOS etiology, diagnosis, clinical subgroups, and subgroup-specific treatments. Endocr Metab Sci. 2024;14:100159.","journal-title":"Endocr Metab Sci"},{"key":"1842_CR8","doi-asserted-by":"publisher","first-page":"659268","DOI":"10.3389\/fendo.2021.659268","volume":"12","author":"X Zhao","year":"2021","unstructured":"Zhao X, Feng X, Zhao X, Jiang Y, Li X, Niu J, et al. How to screen and prevent metabolic syndrome in patients of PCOS early: implications from metabolomics. Front Endocr (Lausanne). 2021;12:659268.","journal-title":"Front Endocr (Lausanne)"},{"key":"1842_CR9","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.3390\/ijms21144853","volume":"21","author":"A Rajska","year":"2020","unstructured":"Rajska A, Buszewska-Forajta M, Racho\u0144 D, Markuszewski MJ. Metabolomic insight into polycystic ovary syndrome\u2014an overview. Int J Mol Sci. 2020;21:4853.","journal-title":"Int J Mol Sci"},{"key":"1842_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cca.2013.12.018","volume":"429","author":"M Murri","year":"2014","unstructured":"Murri M, Insenser M, Escobar-Morreale HF. Metabolomics in polycystic ovary syndrome. Clin Chim Acta. 2014;429:181\u20138.","journal-title":"Clin Chim Acta"},{"key":"1842_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jsbmb.2018.10.012","volume":"186","author":"M Buszewska-Forajta","year":"2019","unstructured":"Buszewska-Forajta M, Racho\u0144 D, Stefaniak A, Wawrzyniak R, Konieczna A, Kowalewska A, et al. Identification of the metabolic fingerprints in women with polycystic ovary syndrome using the multiplatform metabolomics technique. J Steroid Biochem Mol Biol. 2019;186:176\u201384.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1842_CR12","first-page":"118","volume":"24","author":"S Shah","year":"2013","unstructured":"Shah S. Metabolomics of cardiovascular disease: form and function. J Biomol Tech. 2013;24:118\u201327.","journal-title":"J Biomol Tech"},{"key":"1842_CR13","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/metabo12020194","volume":"12","author":"V Gonz\u00e1lez-Covarrubias","year":"2022","unstructured":"Gonz\u00e1lez-Covarrubias V, Mart\u00ednez-Mart\u00ednez E, Del Bosque-Plata L. The potential of metabolomics in biomedical applications. Metabolites. 2022;12:760.","journal-title":"Metabolites"},{"key":"1842_CR14","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.3390\/cells10112832","volume":"10","author":"Q Jin","year":"2021","unstructured":"Jin Q, Ma RCW. Metabolomics in diabetes and diabetic complications: insights from epidemiological studies. Cells. 2021;10:2832.","journal-title":"Cells"},{"key":"1842_CR15","first-page":"1","volume":"17","author":"M Demirel","year":"2023","unstructured":"Demirel M, G\u00fcl A, Koktasoglu F, A\u011fa\u00e7 H, G\u00f6ren A, Karatoprak C, et al. 1H NMR spectroscopy-based serum metabolomics analysis of iron deficiency anemia. J Chem Metrol. 2023;17:1\u201314.","journal-title":"J Chem Metrol"},{"key":"1842_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1055\/s-0041-1729841","volume":"39","author":"S Alesi","year":"2021","unstructured":"Alesi S, Ghelani D, Mousa A. Metabolomic biomarkers in polycystic ovary syndrome: a review of the evidence. Semin Reprod Med. 2021;39:102\u201310.","journal-title":"Semin Reprod Med"},{"key":"1842_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/OGX.0000000000000661","volume":"74","author":"K Brennan","year":"2019","unstructured":"Brennan K, Kroener L, Chazenbalk G, Dumesic D. Polycystic ovary syndrome: impact of lipotoxicity on metabolic and reproductive health. Obstet Gynecol Surv. 2019;74:169\u201376.","journal-title":"Obstet Gynecol Surv"},{"key":"1842_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Revised","year":"2004","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41\u20137.","journal-title":"Hum Reprod"},{"key":"1842_CR19","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/bioinformatics\/btn323","volume":"24","author":"D Kessner","year":"2008","unstructured":"Kessner D, Chambers M, Burke R, Agus D, Mallick P. ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics. 2008;24:2534\u20136.","journal-title":"Bioinformatics"},{"key":"1842_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41587-023-01690-2","volume":"41","author":"R Schmid","year":"2023","unstructured":"Schmid R, Heuckeroth S, Korf A, Smirnov A, Myers O, Dyrlund TS, et al. Integrative analysis of multimodal mass spectrometry data in MZmine 3. Nat Biotechnol. 2023;41:447\u20139.","journal-title":"Nat Biotechnol"},{"key":"1842_CR21","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1038\/s41467-022-32155-w","volume":"13","author":"X Shen","year":"2022","unstructured":"Shen X, Yan H, Wang C, Gao P, Johnson CH, Snyder MP. TidyMass: an object-oriented reproducible analysis framework for LC\u2013MS data. Nat Commun. 2022;13:4365.","journal-title":"Nat Commun"},{"key":"1842_CR22","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41596-022-00710-w","volume":"17","author":"Z Pang","year":"2022","unstructured":"Pang Z, Zhou G, Ewald J, Chang L, Hacariz O, Basu N, et al. Using metaboanalyst 5.0 for LC\u2013HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data. Nat Protoc. 2022;17:1735\u201361.","journal-title":"Nat Protoc"},{"key":"1842_CR23","doi-asserted-by":"publisher","first-page":"1426517","DOI":"10.3389\/fendo.2024.1426517","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Xie M, Wu S, Deng Z, Tang Y, Guan Y, et al. Multi-omics approach to reveal follicular metabolic changes and their effects on oocyte competence in PCOS patients. Front Endocrinol (Lausanne). 2024;15:1426517.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1842_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1741-7015-10-153","volume":"10","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Fu L, Li R, Wang LN, Yang Y, Liu NN, et al. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med. 2012;10:153.","journal-title":"BMC Med"},{"key":"1842_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cca.2015.06.008","volume":"448","author":"W Wang","year":"2015","unstructured":"Wang W, Wang S, Tan S, Wen M, Qian Y, Zeng X, et al. Detection of urine metabolites in polycystic ovary syndrome by UPLC triple-TOF-MS. Clin Chim Acta. 2015;448:39\u201347.","journal-title":"Clin Chim Acta"},{"key":"1842_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jpba.2016.01.025","volume":"121","author":"YX Chen","year":"2016","unstructured":"Chen YX, Zhang XJ, Huang J, Zhou SJ, Liu F, Jiang LL, et al. UHPLC\/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance. J Pharm Biomed Anal. 2016;121:141\u201350.","journal-title":"J Pharm Biomed Anal"},{"key":"1842_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jsbmb.2018.08.008","volume":"185","author":"L Liu","year":"2019","unstructured":"Liu L, Yin Tl, Chen Y, Li Y, Yin L, Ding J, et al. Follicular dynamics of glycerophospholipid and sphingolipid metabolisms in polycystic ovary syndrome patients. J Steroid Biochem Mol Biol. 2019;185:142\u20139.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1842_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature13475","volume":"510","author":"M Maceyka","year":"2014","unstructured":"Maceyka M, Spiegel S. Sphingolipid metabolites in inflammatory disease. Nature. 2014;510:58\u201367.","journal-title":"Nature"},{"key":"1842_CR29","doi-asserted-by":"publisher","first-page":"101251","DOI":"10.1016\/j.plipres.2023.101251","volume":"92","author":"S Mohammed","year":"2023","unstructured":"Mohammed S, Bindu A, Viswanathan A, Harikumar KB. Sphingosine 1-phosphate signaling during infection and immunity. Prog Lipid Res. 2023;92:101251.","journal-title":"Prog Lipid Res"},{"key":"1842_CR30","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1038\/s41598-019-38944-6","volume":"9","author":"J Li","year":"2019","unstructured":"Li J, Xie LM, Song JL, Yau LF, Mi JN, Zhang CR, et al. Alterations of sphingolipid metabolism in different types of polycystic ovary syndrome. Sci Rep. 2019;9:3204.","journal-title":"Sci Rep"},{"key":"1842_CR31","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2306\/scienceasia1513-1874.2023.069","volume":"49","author":"X Fu","year":"2023","unstructured":"Fu X, Liang S. Sphingosine 1-phosphate suppresses the viability and estradiol secretion of mouse granulosa cells by activating Ga12\/13-YAP signaling. ScienceAsia. 2023;49:604\u201311.","journal-title":"ScienceAsia"},{"key":"1842_CR32","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/mrd.23104","volume":"86","author":"C Jia","year":"2019","unstructured":"Jia C, Xu H, Xu Y, Xu Y, Shi Q. Serum metabolomics analysis of patients with polycystic ovary syndrome by mass spectrometry. Mol Reprod Dev. 2019;86:292\u20137.","journal-title":"Mol Reprod Dev"},{"key":"1842_CR33","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00018-012-0917-5","volume":"69","author":"BT Bikman","year":"2012","unstructured":"Bikman BT. A role for sphingolipids in the pathophysiology of obesity-induced inflammation. Cell Mol Life Sci. 2012;69:2135\u201346.","journal-title":"Cell Mol Life Sci"},{"key":"1842_CR34","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.3390\/ijms21124501","volume":"21","author":"E Knuplez","year":"2020","unstructured":"Knuplez E, Marsche G. An updated review of pro- and anti-inflammatory properties of plasma lysophosphatidylcholines in the vascular system. Int J Mol Sci. 2020;21:4501.","journal-title":"Int J Mol Sci"},{"key":"1842_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12958-019-0490-y","volume":"17","author":"Z Sun","year":"2019","unstructured":"Sun Z, Chang HM, Wang A, Song J, Zhang X, Guo J, et al. Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry. Reprod Biol Endocrinol. 2019;17:45.","journal-title":"Reprod Biol Endocrinol"},{"key":"1842_CR36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1080\/09513590.2019.1698026","volume":"36","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Qi J, Xue X, Huang R, Zheng J, Liu W, et al. Ceramide subclasses identified as novel lipid biomarker elevated in women with polycystic ovary syndrome: a pilot study employing shotgun lipidomics. Gynecol Endocrinol. 2020;36:508\u201312.","journal-title":"Gynecol Endocrinol"},{"key":"1842_CR37","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1021\/pr401130w","volume":"13","author":"X Zhao","year":"2014","unstructured":"Zhao X, Xu F, Qi B, Hao S, Li Y, Li Y, et al. Serum metabolomics study of polycystic ovary syndrome based on liquid chromatography\u2013mass spectrometry. J Proteome Res. 2014;13:1101\u201311.","journal-title":"J Proteome Res"},{"key":"1842_CR38","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1007\/s00216-015-8670-x","volume":"407","author":"F Dong","year":"2015","unstructured":"Dong F, Deng D, Chen H, Cheng W, Li Q, Luo R, et al. Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach. Anal Bioanal Chem. 2015;407:4683\u201395.","journal-title":"Anal Bioanal Chem"},{"key":"1842_CR39","doi-asserted-by":"publisher","first-page":"e41456","DOI":"10.1371\/journal.pone.0041456","volume":"7","author":"MN Barber","year":"2012","unstructured":"Barber MN, Risis S, Yang C, Meikle PJ, Staples M, Febbraio MA, et al. Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS ONE. 2012;7:e41456.","journal-title":"PLoS ONE"},{"key":"1842_CR40","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2337\/db12-0495","volume":"62","author":"A Floegel","year":"2013","unstructured":"Floegel A, Stefan N, Yu Z, M\u00fchlenbruch K, Drogan D, Joost HG, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62:639\u201348.","journal-title":"Diabetes"},{"key":"1842_CR41","first-page":"5991","volume":"104","author":"K Aleksandrova","year":"2019","unstructured":"Aleksandrova K, Drogan D, Weikert C, Schulze MB, Fritsche A, Boeing H, et al. Fatty acid\u2013binding protein 4 and risk of type 2 diabetes, myocardial infarction, and stroke: a prospective cohort study. J Clin Endocrinol Metab. 2019;104:5991\u20136002.","journal-title":"J Clin Endocrinol Metab"},{"key":"1842_CR42","doi-asserted-by":"publisher","first-page":"659268","DOI":"10.3389\/fendo.2021.659268","volume":"12","author":"X Zhao","year":"2021","unstructured":"Zhao X, Feng X, Zhao X, Jiang Y, Li X, Niu J, et al. How to screen and prevent metabolic syndrome in patients of PCOS early: implications from metabolomics. Front Endocrinol (Lausanne). 2021;12:659268.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1842_CR43","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/oby.2009.510","volume":"18","author":"SJ Mihalik","year":"2010","unstructured":"Mihalik SJ, Goodpaster BH, Kelley DE, Chace DH, Vockley J, Toledo FG, et al. Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obes (Silver Spring). 2010;18:1695\u2013700.","journal-title":"Obes (Silver Spring)"},{"key":"1842_CR44","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/00365513.2019.1658215","volume":"79","author":"CL Vonica","year":"2019","unstructured":"Vonica CL, Ilie IR, Socaciu C, Moraru C, Georgescu B, Farca\u015f A, et al. Lipidomics biomarkers in women with polycystic ovary syndrome (PCOS) using ultra-high performance liquid chromatography\u2013quadrupole time of flight electrospray in a positive ionization mode mass spectrometry. Scand J Clin Lab Invest. 2019;79:437\u201342.","journal-title":"Scand J Clin Lab Invest"},{"key":"1842_CR45","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/den109","volume":"23","author":"SM Fenkci","year":"2008","unstructured":"Fenkci SM, Fenkci V, Oztekin O, Rota S, Karagenc N. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome. Hum Reprod. 2008;23:1602\u20136.","journal-title":"Hum Reprod"},{"key":"1842_CR46","doi-asserted-by":"publisher","first-page":"E707","DOI":"10.1152\/ajpendo.00532.2018","volume":"316","author":"M Cree-Green","year":"2019","unstructured":"Cree-Green M, Carreau AM, Rahat H, Garcia-Reyes Y, Bergman BC, Pyle L, et al. Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome. Am J Physiol Endocrinol Metab. 2019;316:E707\u201318.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1842_CR47","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.3390\/nu15194153","volume":"15","author":"K Paczkowska","year":"2023","unstructured":"Paczkowska K, Racho\u0144 D, Berg A, Rybka J, Kapczy\u0144ska K, Bolanowski M, et al. Alteration of branched-chain and aromatic amino acid profile as a novel approach in studying polycystic ovary syndrome pathogenesis. Nutrients. 2023;15:4418.","journal-title":"Nutrients"},{"key":"1842_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00726-009-0269-0","volume":"37","author":"G Wu","year":"2009","unstructured":"Wu G. Amino acids: metabolism, functions, and nutrition. Amino Acids. 2009;37:1\u201317.","journal-title":"Amino Acids"},{"key":"1842_CR49","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1039\/C6MB00420B","volume":"12","author":"S RoyChoudhury","year":"2016","unstructured":"RoyChoudhury S, Mishra BP, Khan T, Chattopadhayay R, Lodh I, Ray CD, et al. Serum metabolomics of Indian women with polycystic ovary syndrome using 1H NMR coupled with a pattern recognition approach. Mol Biosyst. 2016;12:3407\u201316.","journal-title":"Mol Biosyst"},{"key":"1842_CR50","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1021\/pr3000317","volume":"11","author":"L Sun","year":"2012","unstructured":"Sun L, Hu W, Liu Q, Hao Q, Sun B, Zhang Q, et al. Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients. J Proteome Res. 2012;11:2937\u201346.","journal-title":"J Proteome Res"},{"key":"1842_CR51","doi-asserted-by":"publisher","first-page":"e4993","DOI":"10.1002\/bmc.4993","volume":"35","author":"E Hou","year":"2021","unstructured":"Hou E, Zhao Y, Hang J, Qiao J. Metabolomics and correlation network analysis of follicular fluid reveals associations between L-tryptophan, L-tyrosine and polycystic ovary syndrome. Biomed Chromatogr. 2021;35:e4993.","journal-title":"Biomed Chromatogr"},{"key":"1842_CR52","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/procel\/pwad065","volume":"15","author":"KH Zhang","year":"2024","unstructured":"Zhang KH, Zhang FF, Zhang ZL, Fang KF, Sun WX, Kong N, et al. Follicle stimulating hormone controls granulosa cell glutamine synthesis to regulate ovulation. Protein Cell. 2024;15:512\u201329.","journal-title":"Protein Cell"},{"key":"1842_CR53","doi-asserted-by":"publisher","first-page":"80472","DOI":"10.18632\/oncotarget.19058","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Liu L, Yin TL, Yang J, Xiong CL. Follicular metabolic changes and effects on oocyte quality in polycystic ovary syndrome patients. Oncotarget. 2017;8:80472\u201381.","journal-title":"Oncotarget"},{"key":"1842_CR54","doi-asserted-by":"publisher","first-page":"9936","DOI":"10.1038\/s41598-022-14201-1","volume":"12","author":"L Wang","year":"2022","unstructured":"Wang L, Zhou C, Sun J, Zhang Q, Lai D. Glutamine and norepinephrine in follicular fluid synergistically enhance the antioxidant capacity of human granulosa cells and the outcome of IVF-ET. Sci Rep. 2022;12:9936.","journal-title":"Sci Rep"},{"key":"1842_CR55","doi-asserted-by":"publisher","first-page":"97008","DOI":"10.1289\/EHP4713","volume":"127","author":"DK Barupal","year":"2019","unstructured":"Barupal DK, Fiehn O. Generating the blood exposome database using a comprehensive text mining and database fusion approach. Environ Health Perspect. 2019;127:97008.","journal-title":"Environ Health Perspect"},{"key":"1842_CR56","first-page":"253","volume":"43","author":"E Peebles","year":"2024","unstructured":"Peebles E. Mahalingaiah S. Environmental exposures and polycystic ovary syndrome: a review. Semin Reprod Med 2024;42:253\u201373","journal-title":"Semin Reprod Med"},{"key":"1842_CR57","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1515\/reveh-2022-0187","volume":"39","author":"K Ghanati","year":"2024","unstructured":"Ghanati K, Jahanbakhsh M, Shakoori A, Aghebat-Bekheir S, Khalili-Rikabadi A, Sadighara P. The association between polycystic ovary syndrome and environmental pollutants based on animal and human study: a systematic review. Rev Environ Health. 2024;39:651\u20137.","journal-title":"Rev Environ Health"},{"key":"1842_CR58","doi-asserted-by":"publisher","first-page":"108473","DOI":"10.1016\/j.reprotox.2023.108473","volume":"121","author":"R Neuvonen","year":"2023","unstructured":"Neuvonen R, Huovinen M, Dorman DC, Laitinen H, Sahlman H. Phthalates and polycystic ovary syndrome: systematic literature review. Reprod Toxicol. 2023;121:108473.","journal-title":"Reprod Toxicol"},{"key":"1842_CR59","doi-asserted-by":"publisher","first-page":"1750368","DOI":"10.1155\/2018\/1750368","volume":"2018","author":"SSS Rowdhwal","year":"2018","unstructured":"Rowdhwal SSS, Chen J. Toxic effects of di-2-ethylhexyl phthalate: an overview. Biomed Res Int. 2018;2018:1750368.","journal-title":"Biomed Res Int"},{"key":"1842_CR60","doi-asserted-by":"publisher","first-page":"104233","DOI":"10.1016\/j.etap.2023.104233","volume":"102","author":"M Zhang","year":"2023","unstructured":"Zhang M, Liu C, Yuan XQ, Cui FP, Miao Y, Yao W, et al. Individual and joint associations of urinary phthalate metabolites with polycystic ovary and polycystic ovary syndrome: results from the TREE cohort. Environ Toxicol Pharmacol. 2023;102:104233.","journal-title":"Environ Toxicol Pharmacol"},{"key":"1842_CR61","doi-asserted-by":"publisher","first-page":"117225","DOI":"10.1016\/j.cca.2023.117225","volume":"540","author":"A Milankov","year":"2023","unstructured":"Milankov A, Milanovi\u0107 M, Milo\u0161evi\u0107 N, Sudji J, Pejakovi\u0107 S, Mili\u0107 N, et al. The effects of phthalate exposure on metabolic parameters in polycystic ovary syndrome. Clin Chim Acta. 2023;540:117225.","journal-title":"Clin Chim Acta"},{"key":"1842_CR62","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4274\/jcrpe.galenos.2020.2020.0037","volume":"12","author":"L Ak\u0131n","year":"2020","unstructured":"Ak\u0131n L, Kendirci M, Narin F, Kurtoglu S, Hatipoglu N, Elmal\u0131 F. Endocrine disruptors and polycystic ovary syndrome: phthalates. J Clin Res Pediatr Endocrinol. 2020;12:393\u2013400.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"1842_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09513590.2019.1630608","volume":"35","author":"S Akg\u00fcl","year":"2019","unstructured":"Akg\u00fcl S, Sur \u00dc, D\u00fcz\u00e7eker Y, Balc\u0131 A, K\u0131z\u0131lkan MP, Kanbur N, et al. Bisphenol A and phthalate levels in adolescents with polycystic ovary syndrome. Gynecol Endocrinol. 2019;35:1\u20135.","journal-title":"Gynecol Endocrinol"},{"key":"1842_CR64","doi-asserted-by":"publisher","first-page":"161793","DOI":"10.1016\/j.scitotenv.2023.161793","volume":"869","author":"J Liang","year":"2023","unstructured":"Liang J, Liu QS, Ren Z, Min K, Yang X, Hao F, et al. Studying paraben-induced Estrogen receptor- and steroid hormone-related endocrine disruption effects via multi-level approaches. Sci Total Environ. 2023;869:161793.","journal-title":"Sci Total Environ"},{"key":"1842_CR65","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1289\/ehp.1205350","volume":"121","author":"KW Smith","year":"2013","unstructured":"Smith KW, Souter I, Dimitriadis I, Ehrlich S, Williams PL, Calafat AM, et al. Urinary Paraben concentrations and ovarian aging among women from a fertility center. Environ Health Perspect. 2013;121:1299\u2013305.","journal-title":"Environ Health Perspect"},{"key":"1842_CR66","doi-asserted-by":"publisher","first-page":"108636","DOI":"10.1016\/j.reprotox.2024.108636","volume":"118","author":"H Pulcastro","year":"2024","unstructured":"Pulcastro H, Ziv-Gal A. Parabens effects on female reproductive health: review of evidence from epidemiological and rodent-based studies. Reprod Toxicol. 2024;118:108636.","journal-title":"Reprod Toxicol"},{"key":"1842_CR67","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/humrep\/dead016","volume":"38","author":"J Ao","year":"2023","unstructured":"Ao J, Qiu W, Huo X, Wang Y, Wang W, Zhang Q, et al. Paraben exposure and couple fecundity: a preconception cohort study. Hum Reprod. 2023;38:726\u201338.","journal-title":"Hum Reprod"},{"key":"1842_CR68","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12940-020-00580-3","volume":"19","author":"J Jurewicz","year":"2020","unstructured":"Jurewicz J, Radwan M, Wielgomas B, Karwacka A, Klimowska A, Ka\u0142u\u017cny P, et al. Parameters of ovarian reserve in relation to urinary concentrations of Parabens. Environ Health. 2020;19:3.","journal-title":"Environ Health"},{"issue":"Suppl 2","key":"1842_CR69","doi-asserted-by":"publisher","first-page":"S279","DOI":"10.33549\/physiolres.934521","volume":"69","author":"M \u0160imkov\u00e1","year":"2020","unstructured":"\u0160imkov\u00e1 M, V\u00edtk\u016f J, Kol\u00e1torov\u00e1 L, Vrb\u00edkov\u00e1 J, Vos\u00e1tkov\u00e1 M, V\u010del\u00e1k J, et al. Endocrine disruptors, obesity, and cytokines: how relevant are they to PCOS? Physiol Res. 2020;69(Suppl 2):S279\u201393.","journal-title":"Physiol Res"},{"key":"1842_CR70","first-page":"92","volume":"13","author":"T Srnovr\u0161nik","year":"2023","unstructured":"Srnovr\u0161nik T, Virant-Klun I, Pinter B. Polycystic ovary syndrome and endocrine disruptors (bisphenols, parabens, and triclosan): a systematic review. Life (Basel). 2023;13:92.","journal-title":"Life (Basel)"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01842-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01842-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01842-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:02:29Z","timestamp":1777525349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-025-01842-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1842"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01842-9","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: the ORCID number of Merve \u0130brahimo\u011flu has been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for this study was obtained by the respective Institutional Review Board of the Bezmialem Vakif University (2022\/367). The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"255"}}